Age: 53.0
Sex: F
Vaccine: COVID19-2, FLUX
Symptoms: Alopecia, Arthralgia, Myalgia, SARS-CoV-2 test, Stress
Clinical narrative: massive hair loss; stress; all my joints and muscle, it is so painful; body aches and pains everywher; This spontaneous case was reported by a patient and describes the occurrence of ALOPECIA (massive hair loss), STRESS (stress), ARTHRALGIA (all my joints and muscle, it is so painful) and MYALGIA (body aches and pains everywher) in an adult female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7140C) for COVID-19 prophylaxis.    Co-suspect product included non-company product INFLUENZA VACCINE for an unknown indication.    Question:Describe relevant medical history/conditions, allergy, concomitant diseases and risk factor.Answer:Seasonal allergies, Compazine and Augmentin. Tested with covid: March 2021.  The patient's past medical history included COVID-19 in March 2021. Previously administered products included for Product used for unknown indication: PFIZER BIONTECH COVID-19 VACCINE (Lot number was EN6201, dose number 1) on 22-Feb-2021, PFIZER BIONTECH COVID-19 VACCINE (Lot number was EN6206, dose number 2) on 17-Mar-2021, PFIZER BIONTECH COVID-19 VACCINE (Lot number was FE3592, dose number 3) on 26-Sep-2021 and Influenza; for Drug use for unknown indication: Compazine and AUGMENTIN [AMOXICILLIN SODIUM;CLAVULANATE POTASSIUM]. Past adverse reactions to the above products included No adverse event with AUGMENTIN [AMOXICILLIN SODIUM; andCLAVULANATE POTASSIUM], Compazine, Influenza, PFIZER BIONTECH COVID-19 VACCINE, PFIZER BIONTECH COVID-19 VACCINE and PFIZER BIONTECH COVID-19 VACCINE. Concurrent medical conditions included Seasonal allergy.   On 12-Sep-2022, the patient received third dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form and dose of INFLUENZA VACCINE (unknown route) 1 dosage form. In September 2022, the patient experienced ALOPECIA (massive hair loss), STRESS (stress), ARTHRALGIA (all my joints and muscle, it is so painful) and MYALGIA (body aches and pains everywher). The patient was treated with DULOXETINE HYDROCHLORIDE (CYMBALTA) for Stress, at an unspecified dose and frequency and ETODOLAC at a dose of twice. At the time of the report, ALOPECIA (massive hair loss), STRESS (stress), ARTHRALGIA (all my joints and muscle, it is so painful) and MYALGIA (body aches and pains everywher) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In March 2021, SARS-CoV-2 test: (Positive) Not hospitalized.     For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   No concomitant product reported by reporter.  Patient received other vaccines in the 4 weeks prior to COVID-19 vaccine. Patient received influenza vaccine on same day. Patient experienced symptoms of massive hair loss, body aches and pains everywhere within less than 2 weeks. Affected parts were legs, hips down the legs to my feet, back, hands, all joints and muscle, it was so painful, if sat too long or laid down too long and tried to stand it was very hard. Within 2-3 weeks, Cymbalta dose was increased twice.